LYFAX Mutual Fund

LYFAX Mutual Fund

NAV$18.71

Fund Essentials - as of Mar 31, 2026

Net Assets
$5M
Expense Ratio
1.71%
Dividend Yield (Current)
1.21%
Holdings
63
Inception Date
Nov 29, 2019
Fund Family
Alpha Centric Fund
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+17.96%
1 Year+54.34%
3 Year+13.10%
5 Year+8.48%

Asset Allocation

Stocks: 92.29%
Cash: 7.71%

Top Holdings

View All →
TickerNameWeight
FXFXXFirst American Treasury Obligations Fund7.72%
GILDGilead Sciences Inc7.18%
AZN:LNAstrazeneca Plc5.63%
VRTXVertex Pharmaceuticals Inc5.60%
IONSIonis Pharmaceuticals, Inc. Com USD0.0013.74%
Top 10 Concentration: 46.76%Report Date: Mar 31, 2026
Download all 63 holdings for LYFAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
1.21%
Frequency
Annually
Latest Distribution
$1.65
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
FundXLS Pro
See how LYFAX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
X-ray my whole portfolio$45/quarter Pro · Cancel anytime
From MarketXLS, trusted since 2014.

LYFAX Mutual Fund Overview

LYFAX Mutual Fund (AlphaCentric Life Sciences and Healthcare Fund Class A) is managed by Alpha Centric Fund with $5.0M in net assets. LYFAX expense ratio is 1.71%, holding 63 positions across sectors including Health Care, Financials. Inception date: 2019-11-29.

LYFAX performance shows a YTD return of 17.96%. The 1-year return is 54.34% and the 5-year return is 8.48%. LYFAX dividend yield stands at 1.21%, paid annually.

LYFAX top holdings include First American Treasury Obligations Fund (7.7%), Gilead Sciences Inc (7.2%), Astrazeneca Plc (5.6%), Vertex Pharmaceuticals Inc (5.6%), Ionis Pharmaceuticals, Inc. Com USD0.001 (3.7%). Go to all LYFAX holdings, LYFAX sectors, or LYFAX dividends.

LYFAX can be compared against other funds. Use LYFAX overlap to find shared positions, or LYFAX vs another fund for a side-by-side view. LYFAX alternatives are available via the screener, along with tax-loss harvesting opportunities.